1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Gaspari, Z.
Patthy, A.
Graf, L.
Perczel, A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
269
527
537
10.1046/j.0014-2956.2001.02685.x
11856311
Comparative structure analysis of proteinase inhibitors from the desert locust, Schistocerca gregaria.
2002
10.2210/pdb1kj0/pdb
pdb_00001kj0
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
3828.314
SERINE PROTEASE INHIBITOR I
Residues 20-54
1
syn
polymer
SCHISTOCERCA GREGARIA TRYPSIN INHIBITOR (SGTI)
no
no
EQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPH
EQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-12-12
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI[L30R, K31M]
SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI
PROTEINASE INHIBITOR PMP-C (NMR, 36 STRUCTURES)
RCSB
Y
RCSB
2001-12-04
REL
REL
SOLID PHASE PEPTIDE SYNTHESIS, FMOC STRATEGY, SEQUENCE NATURALLY FOUND IN SCHISTOCERCA GREGARIA (DESERT LOCUST)
sample
structures with acceptable covalent geometry, structures with the least restraint violations
100
10
2D NOESY
0
3.0
ambient
300
K
the structures are based on a total of 342 NOE distance restraints (108 long-range)
simulated annealing
6
closest to the average
2.4mM SGTI NA
90% H2O/10% D2O
Brunger
refinement
X-PLOR
3.851
Brunger
structure solution
X-PLOR
3.851
500
Bruker
DRX
GLU
1
n
1
GLU
1
A
GLN
2
n
2
GLN
2
A
GLU
3
n
3
GLU
3
A
CYS
4
n
4
CYS
4
A
THR
5
n
5
THR
5
A
PRO
6
n
6
PRO
6
A
GLY
7
n
7
GLY
7
A
GLN
8
n
8
GLN
8
A
THR
9
n
9
THR
9
A
LYS
10
n
10
LYS
10
A
LYS
11
n
11
LYS
11
A
GLN
12
n
12
GLN
12
A
ASP
13
n
13
ASP
13
A
CYS
14
n
14
CYS
14
A
ASN
15
n
15
ASN
15
A
THR
16
n
16
THR
16
A
CYS
17
n
17
CYS
17
A
ASN
18
n
18
ASN
18
A
CYS
19
n
19
CYS
19
A
THR
20
n
20
THR
20
A
PRO
21
n
21
PRO
21
A
THR
22
n
22
THR
22
A
GLY
23
n
23
GLY
23
A
VAL
24
n
24
VAL
24
A
TRP
25
n
25
TRP
25
A
ALA
26
n
26
ALA
26
A
CYS
27
n
27
CYS
27
A
THR
28
n
28
THR
28
A
ARG
29
n
29
ARG
29
A
LYS
30
n
30
LYS
30
A
GLY
31
n
31
GLY
31
A
CYS
32
n
32
CYS
32
A
PRO
33
n
33
PRO
33
A
PRO
34
n
34
PRO
34
A
HIS
35
n
35
HIS
35
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
O
H
CYS
ALA
17
26
1.46
1
A
A
O
H
THR
THR
20
22
1.58
3
A
A
O
H
ASP
ASN
13
15
1.52
4
A
A
O
H
CYS
ALA
17
26
1.51
7
A
A
O
H
CYS
ALA
17
26
1.59
8
A
A
O
HG1
GLN
THR
8
9
1.52
10
A
A
OE1
H
GLU
CYS
3
4
1.43
1
A
ARG
29
0.264
SIDE CHAIN
2
A
ARG
29
0.283
SIDE CHAIN
3
A
ARG
29
0.288
SIDE CHAIN
4
A
ARG
29
0.215
SIDE CHAIN
5
A
ARG
29
0.263
SIDE CHAIN
6
A
ARG
29
0.219
SIDE CHAIN
7
A
ARG
29
0.193
SIDE CHAIN
8
A
ARG
29
0.237
SIDE CHAIN
9
A
ARG
29
0.313
SIDE CHAIN
10
A
ARG
29
0.302
SIDE CHAIN
1
A
GLU
3
178.07
-27.61
1
A
THR
5
-167.05
-55.40
1
A
PRO
6
-59.06
-96.32
1
A
ASP
13
59.32
126.77
1
A
CYS
14
78.17
-28.87
1
A
ASN
18
58.63
142.99
1
A
PRO
21
-67.87
55.89
1
A
THR
22
174.03
28.89
1
A
VAL
24
-29.57
126.85
1
A
LYS
30
-136.33
-60.37
2
A
GLN
2
-144.41
22.50
2
A
GLU
3
-177.47
-30.63
2
A
CYS
4
66.97
176.45
2
A
THR
5
-161.98
-57.68
2
A
PRO
6
-65.30
1.67
2
A
GLN
8
-147.78
14.70
2
A
THR
9
37.31
94.46
2
A
GLN
12
-131.06
-67.16
2
A
ASP
13
-174.02
-131.79
2
A
CYS
14
-33.57
-38.12
2
A
PRO
21
-75.82
47.71
2
A
THR
22
164.67
42.09
2
A
VAL
24
71.42
-5.05
2
A
TRP
25
36.26
-153.79
2
A
ALA
26
-140.04
-64.19
2
A
CYS
27
59.45
110.92
2
A
THR
28
-81.11
-151.43
2
A
CYS
32
57.75
139.33
3
A
CYS
4
176.24
167.04
3
A
THR
5
-127.10
-165.34
3
A
THR
9
-177.14
131.89
3
A
ASP
13
-42.46
93.62
3
A
CYS
14
63.65
-54.00
3
A
ASN
15
-52.89
88.37
3
A
PRO
21
-69.46
59.69
3
A
THR
22
161.63
36.02
3
A
VAL
24
50.08
176.78
3
A
TRP
25
-152.61
-158.16
3
A
ALA
26
-177.92
85.30
3
A
LYS
30
177.25
90.26
3
A
PRO
34
-74.17
-88.86
4
A
GLN
2
-176.98
132.86
4
A
GLU
3
-132.70
-64.14
4
A
THR
5
-165.48
-58.29
4
A
THR
9
60.53
143.42
4
A
LYS
10
-138.16
-39.02
4
A
LYS
11
66.45
-78.74
4
A
GLN
12
45.39
89.08
4
A
ASP
13
57.22
-150.02
4
A
ASN
18
51.08
93.24
4
A
CYS
19
-50.42
172.10
4
A
THR
22
167.37
35.75
4
A
VAL
24
-164.35
-35.97
4
A
TRP
25
60.73
175.67
4
A
ALA
26
-131.47
-53.27
4
A
CYS
27
61.48
127.19
4
A
ARG
29
58.62
155.43
4
A
LYS
30
43.64
-96.89
5
A
GLN
2
-171.53
125.10
5
A
CYS
4
179.68
154.04
5
A
THR
5
-170.56
52.50
5
A
PRO
6
-94.59
-62.64
5
A
GLN
8
-114.39
-144.83
5
A
THR
9
-149.74
-146.47
5
A
LYS
10
-173.20
102.18
5
A
GLN
12
43.12
-147.42
5
A
ASP
13
-63.06
-134.89
5
A
ASN
18
-163.35
119.21
5
A
THR
22
168.93
29.23
5
A
CYS
27
57.00
107.60
5
A
ARG
29
58.84
106.30
5
A
LYS
30
-176.90
-37.41
6
A
GLU
3
-178.16
-31.14
6
A
THR
5
-163.17
-57.02
6
A
PRO
6
-78.22
28.01
6
A
THR
9
50.24
107.26
6
A
GLN
12
37.11
-142.59
6
A
ASP
13
-127.83
-100.53
6
A
PRO
21
-75.35
46.09
6
A
THR
22
177.49
30.26
6
A
VAL
24
80.33
-31.27
6
A
TRP
25
46.64
-171.88
6
A
ALA
26
-156.16
-55.90
6
A
CYS
27
63.32
121.79
7
A
GLN
2
173.78
79.26
7
A
CYS
4
83.55
178.34
7
A
THR
5
-173.50
-55.38
7
A
GLN
8
-62.37
-97.21
7
A
THR
9
171.70
151.59
7
A
LYS
11
-95.58
51.53
7
A
ASP
13
41.88
-106.38
7
A
ASN
18
57.49
114.31
7
A
PRO
21
-69.04
54.35
7
A
THR
22
163.28
37.27
7
A
VAL
24
76.08
-11.29
7
A
TRP
25
39.81
-149.70
7
A
ALA
26
-135.20
-57.13
7
A
CYS
27
57.62
100.30
7
A
LYS
30
-171.27
-41.18
7
A
CYS
32
50.34
-172.77
7
A
PRO
34
-75.86
-92.52
8
A
GLN
2
177.78
51.27
8
A
THR
5
-168.29
-58.90
8
A
GLN
8
-61.09
-141.88
8
A
THR
9
-170.98
90.95
8
A
GLN
12
-152.06
-45.73
8
A
ASP
13
-165.48
-145.46
8
A
ASN
18
40.05
106.35
8
A
THR
22
163.02
36.09
8
A
VAL
24
54.70
161.47
8
A
CYS
27
63.01
89.97
8
A
LYS
30
-141.25
15.55
9
A
GLU
3
35.07
36.07
9
A
CYS
4
91.10
169.22
9
A
THR
5
-176.14
-57.14
9
A
PRO
6
-73.80
35.16
9
A
GLN
8
-96.52
47.62
9
A
LYS
11
-54.51
86.44
9
A
ASP
13
-139.24
-120.81
9
A
THR
16
-104.37
79.77
9
A
THR
22
164.07
45.49
9
A
VAL
24
51.06
169.70
9
A
ALA
26
-127.33
-65.53
9
A
CYS
27
67.65
158.99
9
A
ARG
29
-115.98
-141.91
9
A
LYS
30
73.50
61.94
9
A
PRO
34
-72.31
-84.11
10
A
GLU
3
-143.37
-60.60
10
A
THR
5
-153.88
-62.13
10
A
THR
9
57.43
152.74
10
A
LYS
10
-114.73
-149.86
10
A
LYS
11
-155.47
66.94
10
A
GLN
12
-98.99
36.66
10
A
ASP
13
59.99
109.51
10
A
CYS
14
66.61
-67.85
10
A
ASN
15
-59.81
94.01
10
A
PRO
21
-68.40
53.86
10
A
THR
22
166.50
47.08
10
A
VAL
24
67.11
-47.85
10
A
TRP
25
60.28
-167.44
10
A
ALA
26
-153.06
-53.30
10
A
CYS
27
64.75
142.38
10
A
LYS
30
-177.68
-45.95
SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGTI
1
N
N
disulf
2.016
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
19
A
SG
CYS
19
1_555
disulf
2.018
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
32
A
SG
CYS
32
1_555
disulf
2.020
A
CYS
17
A
SG
CYS
17
1_555
A
CYS
27
A
SG
CYS
27
1_555
HYDROLASE
serine protease inhibition, inhibitor specificity, HYDROLASE
SGP1_SCHGR
UNP
1
1
O46162
MKLALALCAAFLLVVLVQAEQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPHKREVTCEPGTTFKDKCNTCRCGSDGK
SAACTLKACPQK
20
54
1KJ0
1
35
O46162
A
1
1
35